evolcSign inStart free
Menu

Resolution Therapeutics

Develops regenerative macrophage cell therapies for patients with inflammatory and fibrotic diseases

London, United KingdomFounded 2017resolution-tx.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-27

About Resolution Therapeutics

Resolution Therapeutics develops engineered regenerative macrophage therapies, including an ex vivo cell therapy and an in vivo programme. Its initial focus is end-stage liver disease, including decompensated cirrhosis.

The company’s lead candidate, RTX001, is being evaluated in a Phase I/II clinical trial for end-stage liver disease. Its stated goal is to reduce complications and the need for liver transplantation and improve patient outcomes.

Founded in 2017, Resolution Therapeutics is headquartered in London. Its work builds on research at the University of Edinburgh.

Product: Develops regenerative macrophage cell therapies, including RTX001 for end-stage liver disease.

Jobs at Resolution Therapeutics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Richmond Pharmacology

    Early-phase clinical trial CRO in London running first-in-human and gene-editing studies for pharma and biotech sponsors
    London, United KingdomBiotech & pharmaFounded 20013 open jobs
    New on EvolcRemote-friendly

  • Rinri Therapeutics

    Develops regenerative cell therapies for people with sensorineural hearing loss
    Sheffield, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • RoukenBio

    Preclinical immunology research and assay services for biotechnology and drug development companies
    Motherwell, United KingdomBiotech & pharmaFounded 20151 open job
    Remote-friendlySalary transparent

  • Rxbiologics

    Antibody discovery services for biologics drug discovery programmes, built on a proprietary human antibody library
    Cambridge, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

  • Scancell

    Clinical-stage immunotherapy developer for difficult-to-treat cancers, using Immunobody and Moditope platforms
    Oxford, United KingdomBiotech & pharmaFounded 1996
    New on Evolc

  • Scripta Therapeutics

    Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapies
    Oxford, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google Analytics 4
  • Google reCAPTCHA
  • WordPress
  • jQuery
  • nginx